← Leaderboards
Kevin M Shannon
University Of California San Francisco
$44,683,939
Attributed
$44,683,939
Total exposure
24
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,715,061 · 25
By mechanism
U54$28,260,200 · 10
R01$11,783,091 · 5
T32$11,707,494 · 2
U01$8,689,093 · 1
R37$3,359,623 · 1
P01$2,513,281 · 2
Top collaborators
- David W. Clapp10 shared
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationMalignant NeoplasmsSignal TransductionResearch PersonnelNf1 GeneCellsGenesGeneticLeukemiaAllelesMutantResponseMolecularPathway InteractionsFundingScientistBaseTumor Suppressor GenesMyeloproliferative DiseaseTranslational ResearchTumorOncogenicHematopoieticResources
Grant awards (138)
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,300,532
U54 · FY2025 · CA
Selectively Targeting Oncogenic NRAS in Cancer$516,416
R01 · FY2025 · CA · contact PI
Developmental Research Program$287,566
U54 · FY2025 · CA · contact PI
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML$287,566
U54 · FY2025 · CA · contact PI
Career Enhancement Program$287,565
U54 · FY2025 · CA · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,208,392
U54 · FY2024 · CA
Selectively Targeting Oncogenic NRAS in Cancer$490,596
R01 · FY2024 · CA · contact PI
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML$387,575
U54 · FY2024 · CA · contact PI
Developmental Research Program$93,429
U54 · FY2024 · CA · contact PI
Career Enhancement Program$93,429
U54 · FY2024 · CA · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,139,494
U54 · FY2023 · CA
Selectively Targeting Oncogenic NRAS in Cancer$506,088
R01 · FY2023 · CA · contact PI
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML$375,487
U54 · FY2023 · CA · contact PI
Developmental Research Program$92,867
U54 · FY2023 · CA · contact PI
Career Enhancement Program$92,867
U54 · FY2023 · CA · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,139,494
U54 · FY2022 · CA
Selectively Targeting Oncogenic NRAS in Cancer$506,084
R01 · FY2022 · CA · contact PI
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML$375,486
U54 · FY2022 · CA · contact PI
Developmental Research Program$93,910
U54 · FY2022 · CA · contact PI
Career Enhancement Program$93,910
U54 · FY2022 · CA · contact PI
Developmental and Hyperactive Ras Tumor (DHART) SPORE$2,198,683
U54 · FY2021 · CA
Selectively Targeting Oncogenic NRAS in Cancer$531,791
R01 · FY2021 · CA · contact PI
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML$387,509
U54 · FY2021 · CA · contact PI
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies$338,672
R01 · FY2021 · CA · contact PI
Developmental Research Program$90,209
U54 · FY2021 · CA · contact PI
Career Enhancement Program$90,209
U54 · FY2021 · CA · contact PI
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies$338,672
R01 · FY2020 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,124,182
U54 · FY2019 · CA
Selectively Targeting Oncogenic NRAS in Cancer$482,100
R01 · FY2019 · CA · contact PI
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia$395,809
U54 · FY2019 · CA · contact PI
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies$328,511
R01 · FY2019 · CA · contact PI
Developmental Research Program$111,136
U54 · FY2019 · CA · contact PI
Career Development Program$89,217
U54 · FY2019 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,102,055
U54 · FY2018 · CA
Selectively Targeting Oncogenic NRAS in Cancer$497,010
R01 · FY2018 · CA · contact PI
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia$425,561
U54 · FY2018 · CA · contact PI
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies$338,672
R01 · FY2018 · CA · contact PI
Developmental Research Program$119,512
U54 · FY2018 · CA · contact PI
Career Development Program$95,959
U54 · FY2018 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,271,783
U54 · FY2017 · CA
Selectively Targeting Oncogenic NRAS in Cancer$497,010
R01 · FY2017 · CA · contact PI
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia$419,407
U54 · FY2017 · CA · contact PI
In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies$338,672
R01 · FY2017 · CA · contact PI
Research Training in Childhood Cancer$290,621
T32 · FY2017 · CA · contact PI
Developmental Research Program$117,214
U54 · FY2017 · CA · contact PI
Career Development Program$93,898
U54 · FY2017 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,162,000
U54 · FY2016 · CA
Selectively Targeting Oncogenic NRAS in Cancer$550,502
R01 · FY2016 · CA · contact PI
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia$408,012
U54 · FY2016 · CA · contact PI
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers$328,888
R01 · FY2016 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$304,773
R37 · FY2016 · CA · contact PI
Research Training in Childhood Cancer$292,319
T32 · FY2016 · CA · contact PI
Developmental Research Program$103,346
U54 · FY2016 · CA · contact PI
Career Development Program$80,236
U54 · FY2016 · CA · contact PI
Developmental and HyperActive Ras Tumor SPORE$2,384,507
U54 · FY2015 · CA
Selectively Targeting Oncogenic NRAS in Cancer$579,512
R01 · FY2015 · CA · contact PI
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia$431,271
U54 · FY2015 · CA · contact PI
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers$328,888
R01 · FY2015 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$304,773
R37 · FY2015 · CA · contact PI
Research Training in Childhood Cancer$270,215
T32 · FY2015 · CA · contact PI
Developmental Research Program$104,458
U54 · FY2015 · CA · contact PI
Career Development Program$104,458
U54 · FY2015 · CA · contact PI
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers$318,099
R01 · FY2014 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$295,630
R37 · FY2014 · CA · contact PI
Research Training in Childhood Cancer$266,057
T32 · FY2014 · CA · contact PI
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers$325,948
R01 · FY2013 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$286,486
R37 · FY2013 · CA · contact PI
Research Training in Childhood Cancer$267,273
T32 · FY2013 · CA · contact PI
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22$443,763
P01 · FY2012 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$320,588
R37 · FY2012 · CA · contact PI
Research Training in Childhood Cancer$269,083
T32 · FY2012 · CA · contact PI
Medical Scientist Training Program$1,535,030
T32 · FY2011 · GM · contact PI
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22$433,979
P01 · FY2011 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$300,946
R37 · FY2011 · CA · contact PI
Research Training in Childhood Cancer$258,166
T32 · FY2011 · CA · contact PI
HEMATOPOIETIC MALIGNANCIES PROGRAM$69,688
P30 · FY2011 · CA · contact PI
Medical Scientist Training Program$43,858
T32 · FY2011 · GM · contact PI
ID OF MOLECULES THAT SUBSTITUTE FOR ACTIVE NOTCH1 IN T LINEAGE LEUKEMOGENESIS$2,253
P41 · FY2011 · RR · contact PI
Medical Scientist Training Program$1,563,278
T32 · FY2010 · GM · contact PI
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22$483,413
P01 · FY2010 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$310,254
R37 · FY2010 · CA · contact PI
Role of PTPN11 Mutations in Myeloid Leukemogenesis$278,390
R01 · FY2010 · CA · contact PI
Research Training in Childhood Cancer$235,992
T32 · FY2010 · CA · contact PI
HEMATOPOIETIC MALIGNANCIES PROGRAM$70,558
P30 · FY2010 · CA · contact PI
Medical Scientist Training Program$1,512,143
T32 · FY2009 · GM · contact PI
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22$455,814
P01 · FY2009 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$310,254
R37 · FY2009 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$307,209
R37 · FY2009 · CA · contact PI
Role of PTPN11 Mutations in Myeloid Leukemogenesis$278,390
R01 · FY2009 · CA · contact PI
Research Training in Childhood Cancer$248,017
T32 · FY2009 · CA · contact PI
Mouse Models of Myeloid Leukemia$127,594
U01 · FY2009 · CA · contact PI
HEMATOPOIETIC MALIGNANCIES PROGRAM$71,725
P30 · FY2009 · CA · contact PI
Medical Scientist Training Program$43,204
T32 · FY2009 · GM · contact PI
Medical Scientist Training Program$1,504,432
T32 · FY2008 · GM · contact PI
Mouse Models of Myeloid Leukemia$1,055,331
U01 · FY2008 · CA · contact PI
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22$429,683
P01 · FY2008 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$309,845
R37 · FY2008 · CA · contact PI
Research Training in Childhood Cancer$248,995
T32 · FY2008 · CA · contact PI
HEMATOPOIETIC MALIGNANCIES PROGRAM$74,361
P30 · FY2008 · CA · contact PI
Medical Scientist Training Program$1,449,104
T32 · FY2007 · GM · contact PI
Mouse Models of Myeloid Leukemia$1,048,411
U01 · FY2007 · CA · contact PI
Translational Investigation of KRas & NF1 in Myeloid Leukemia$308,865
R37 · FY2007 · CA · contact PI
Role of PTPN11 Mutations in Myeloid Leukemogenesis$265,033
R01 · FY2007 · CA · contact PI
Research Training in Childhood Cancer$250,655
T32 · FY2007 · CA · contact PI
HEMATOPOIETIC MALIGNANCIES PROGRAM$64,895
P30 · FY2007 · CA · contact PI
Medical Scientist Training Program$1,159,052
T32 · FY2006 · GM · contact PI
Mouse Models of Myeloid Leukemia$1,015,189
U01 · FY2006 · CA · contact PI
Translational Investigation of NF1 in Myeloid Luekemia$296,249
R01 · FY2006 · CA · contact PI
Role of PTPN11 Mutations in Myeloid Leukemogenesis$272,949
R01 · FY2006 · CA · contact PI
Mouse Models of Myeloid Leukemia$835,721
U01 · FY2005 · CA
Translational Investigation of NF1 in Myeloid Luekemia$303,379
R01 · FY2005 · CA
Role of PTPN11 Mutations in Myeloid Leukemogenesis$279,518
R01 · FY2005 · CA
Mouse Models of Myeloid Leukemia$850,000
U01 · FY2004 · CA
Translational Investigation of NF1 in Myeloid Luekemia$303,379
R01 · FY2004 · CA
Role of PTPN11 Mutations in Myeloid Leukemogenesis$279,518
R01 · FY2004 · CA
MOUSE MODELS OF MYELOID LEUKEMIA$1,105,106
U01 · FY2003 · CA
Translational Investigation of NF1 in Myeloid Luekemia$302,544
R01 · FY2003 · CA
MOUSE MODELS OF MYELOID LEUKEMIA$1,082,737
U01 · FY2002 · CA
Translational Investigation of NF1 in Myeloid Luekemia$300,125
R01 · FY2002 · CA
ISOLATION AND ANALYSIS OF CANDIDATE 7Q TUMOR SUPPRESSOR GENES$0
P01 · FY2002 · CA
EPIDEMIOLOGY, TREATMENT, BIOLOGY OF JUVENILE MYELOGENOUS LEUKEMIA &MONOSOMY 7$0
M01 · FY2002 · RR
MOUSE MODELS OF MYELOID LEUKEMIA$873,029
U01 · FY2001 · CA
TRANSLATIONAL INVESTIGATION OF NF1 IN MYELOID LEUKEMIA$200,789
R01 · FY2001 · CA
TRANSLATIONAL INVESTIGATION OF NF1 IN MYELOID LEUKEMIA$36,409
R01 · FY2001 · CA
ISOLATION AND ANALYSIS OF CANDIDATE 7Q TUMOR SUPPRESSOR GENES$0
P01 · FY2001 · CA
Hematopoietic maligancies program$0
P30 · FY2001 · CA
Hematopoietic maligancies program$0
P30 · FY2001 · CA
ISOLATION AND ANALYSIS OF CANDIDATE 7Q TUMOR SUPPRESSOR GENES$0
P01 · FY2001 · CA
EPIDEMIOLOGY, TREATMENT, BIOLOGY OF JUVENILE MYELOGENOUS LEUKEMIA &MONOSOMY 7$0
M01 · FY2001 · RR
MOUSE MODELS OF MYELOID LEUKEMIA$695,975
U01 · FY2000 · CA
ISOLATION AND ANALYSIS OF CANDIDATE 7Q TUMOR SUPPRESSOR GENES$266,629
P01 · FY2000 · CA
TRANSLATIONAL INVESTIGATION OF NF1 IN MYELOID LEUKEMIA$208,940
R01 · FY2000 · CA
TRANSLATIONAL INVESTIGATION OF NF1 IN MYELOID LEUKEMIA$35,348
R01 · FY2000 · CA
EPIDEMIOLOGY, TREATMENT, BIOLOGY OF JUVENILE MYELOGENOUS LEUKEMIA &MONOSOMY 7$25,799
M01 · FY2000 · RR
NNFF CONSORTIUM:MOLECULAR AND CELL BIOLOGY OF NF1&NF2$23,000
R13 · FY2000 · NS
Hematopoietic maligancies program$0
P30 · FY2000 · CA
EPIDEMIOLOGY, TREATMENT, BIOLOGY OF JUVENILE MYELOGENOUS LEUKEMIA &MONOSOMY 7$0
M01 · FY2000 · RR
EPIDEMIOLOGY, TREATMENT, BIOLOGY OF JUVENILE MYELOGENOUS LEUKEMIA &MONOSOMY 7$0
M01 · FY2000 · RR